Strategic Blueprint’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Strategic Blueprint's AMGN Position: Q2 2026 in Review
Strategic Blueprint increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $69.1K and bringing the position to 1,477 shares worth $535K. The position accounts for 0.03% of the portfolio, ranked #445.
Strategic Blueprint first reported a position in AMGN in Q3 2019 and has held it in 20 quarters since. The position peaked at $2.45M in Q3 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Strategic Blueprint held 1,477 shares of Amgen worth $535K as of Q2 2026.
- Strategic Blueprint bought 202 Amgen shares in Q2 2026, an estimated $69.1K.
- Amgen made up 0.03% of Strategic Blueprint's portfolio in Q2 2026, its #445 holding.
- Strategic Blueprint first reported a position in Amgen in Q3 2019 and has held it in 20 quarters since.
- Strategic Blueprint's Amgen position peaked at $2.45M in Q3 2025.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.